Julia Harwardt is a Bench Scientist in the Antibody Discovery & Protein Engineering department at Merck KGaA. She joined the company after completing her PhD in the group of Prof. Dr. Harald Kolmar at the Technical University of Darmstadt. With a strong background in biochemistry and antibody engineering, her research currently focuses on the development of multifunctional antibody derivaties for immunological and immunoncological therapies. Focusing on innovative therapies, she is contributing to advance the company's pipeline.